Filing Details
Passage BIO, Inc. (NASDAQ:PASG) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 10, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:PASG
Passage BIO, Inc. (PASG) Files Quarterly Report for Q0
Passage BIO, Inc. (NASDAQ:PASG) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 10, 2026.
At publication ·
What changed
Passage BIO, Inc. (NASDAQ:PASG) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Passage BIO, Inc. (NASDAQ: PASG) filed its quarterly report (Form 10-Q) with the SEC on August 10, 2026.
- The company's stock trades at $4.32 with a market capitalization of $33.1 million.
- The 10-Q filing includes unaudited financial statements and management commentary on business performance, though specific revenue figures were not disclosed in this summary.
Market Context
Passage BIO, Inc.'s stock currently trades at $4.32 with a market capitalization of $33.1M.
The 10-Q provides Passage BIO, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Passage BIO, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PASG Stock Page
Frequently Asked Questions
Where can I read PASG's SEC filings?
Browse all filings on our PASG SEC filings page.
What types of SEC filings does Passage BIO, Inc. file?
Public companies like Passage BIO, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.